Cover Image

Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study

Thomas Rappl,1 Daryousch Parvizi,1 Herwig Friedl,2 Maria Wiedner,1 Simone May,1 Bettina Kranzelbinder,3 Paul Wurzer,1 Bengt Hellbom1,&dagger; 1Department of Plastic and Reconstructive Surgery, Medical University Graz, Graz, Austria; 2Institute of Statistics, Graz University of Technology, Graz,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rappl T (Author), Parvizi D (Author), Friedl H (Author), Wiedner M (Author), May S (Author), Kranzelbinder B (Author), Wurzer P (Author), Hellbom B (Author)
Format:	Book
Published:	Dove Medical Press, 2013-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
by: Prager W
Published: (2013)

Comparison of neurotoxic potency between a novel chinbotulinumtoxinA with onabotulinumtoxinA, incobotulinumtoxinA and lanbotulinumtoxinA in rats
by: Feng Y, et al.
Published: (2017)

Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems
by: Kazerooni R, et al.
Published: (2021)

Real-World Safety And Effectiveness Of OnabotulinumtoxinA Treatment Of Crow's Feet Lines And Glabellar Lines: Results Of A Korean Postmarketing Surveillance Study
by: Yi DJ, et al.
Published: (2019)

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
by: Muthukumar M, et al.
Published: (2017)

IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
by: Yutskovskaya Y, et al.
Published: (2015)

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
by: Abogunrin S, et al.
Published: (2015)

OnabotulinumtoxinA for chronic migraine: a critical appraisal
by: Gooriah R, et al.
Published: (2015)

Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
by: Rungsima Wanitphakdeedecha, et al.
Published: (2020)

Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
by: Jost WH, et al.
Published: (2015)

A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA
by: Rupp DC, et al.
Published: (2023)

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy
by: Carlo Di Gregorio, et al.
Published: (2023)

Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women
by: Ada Trindade de Almeida, et al.
Published: (2024)

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013)

AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis
by: Carlo Lazzaro, et al.
Published: (2020)

One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA
by: de Sanctis Pecora C
Published: (2020)

Prospective evaluation of incobotulinumtoxinA in the management of the masseter using two different injection techniques
by: Nikolis A, et al.
Published: (2018)

OnabotulinumtoxinA is now an important tool for managing pediatric neurogenic lower urinary tract dysfunction
by: Brendan T. Frainey, et al.
Published: (2024)

Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)
by: Meghdad Hosseini, et al.
Published: (2023)

Intralesional cryotherapy with triamcinolone and onabotulinumtoxinA injections for umbilical keloid: A case report
by: Jennifer VH Tran, et al.
Published: (2021)

Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA
by: Jörg Wissel, et al.

IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series
by: da Cunha ALG, et al.
Published: (2023)

IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study
by: Pavicic T, et al.
Published: (2015)

A Novel OnabotulinumtoxinA Treatment Technique to Obtain Predictable Outcomes in Eyebrow Position and Shape
by: Angelo-Khattar M
Published: (2020)

Tratamento da hiperidrose palmar com onabotulinumtoxinA veiculada por iontoforese ou fonoforese: relato de casos Use of iontophoresis or phonophoresis for delivering onabotulinumtoxinA in the treatment of palmar hyperidrosis: a report on four cases
by: Patrícia Cristina Andrade, et al.
Published: (2011)

Hereditary cold-induced palmar erythema with dysesthesia: A novel entity with response to onabotulinumtoxinA injections
by: Injae Jung, BS, et al.
Published: (2024)

Switching from onabotulinumtoxin-A to abobotulinumtoxin-A in children with cerebral palsy treated for spasticity: A retrospective safety and efficacy evaluation
by: Nigar Dursun, et al.
Published: (2019)

Global facial rejuvenation with one treatment of incobotulinumtoxinA, hyaluronic acid, and calcium hydroxyapatite results in long-term patient-reported satisfaction
by: Jasmine Thai Lu, BS, et al.
Published: (2023)

Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials
by: Raquel Martins Arruda, et al.
Published: (2018)

Self-Administered Low-Dose Inhaled Methoxyflurane (Penthrox) during Administration of OnabotulinumtoxinA for Chronic Migraines: A Real World Case Series
by: Robert Hauptman
Published: (2019)

Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
by: Andrew M. Blumenfeld, et al.
Published: (2020)

Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysisCapsule Summary
by: Mitchell F. Brin, MD, et al.
Published: (2024)

Corrigendum to AbobotulinumtoxinA injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial
by: Thierry Lejeune, et al.
Published: (2021)

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study
by: Hsiangkuo Yuan, et al.
Published: (2024)

Long term outcome for onabotulinumtoxinA (Botox) therapy in chronic migraine: A 2-year prospective follow-up audit of patients attending the Hull (UK) migraine clinic
by: Fayyaz Ahmed, et al.
Published: (2021)

Intravesicular Onabotulinumtoxin A Hemorrhage on Rivaroxaban
by: Allison Eubanks, et al.
Published: (2019)

Botulinum toxin type-A in the treatment of glabellar lines
by: Leslie Winter, et al.
Published: (2009)

Botulinum toxin type A for the management of glabellar rhytids
by: Anne Marie Tremaine, et al.
Published: (2010)

GLABELLAR FLAP RECONSTRUCTION FOR DEFECTS BELOW MEDIAL CANTHUS
by: Georgi Balchev, et al.
Published: (2024)

Glabellar vertical line as a reference goal for anteroposterior maxillary position
by: Marcos J. Carruitero, et al.